News | November 05, 2021
Prime Therapeutics to list Semglee and Insulin Glargine
Biocon Biologics and Viatris co-developed the products
Biocon Biologics and Viatris co-developed the products
This is the eighth Covid-19 vaccine to receive Emergency Use Listing
The Akovaz brand and generic market had U.S. sales of approximately US $ 67.5 million MAT for the most recent twelve months ending in August 2021
The BiCNU brand and generic market had U.S. sales of approximately US $ 19.4 million MAT for the most recent twelve months ending in August 2021, according to IQVIA Health
Transformational partnership establishes PCI as a CDMO and broadens capabilities across drug product lifecycle
An amount of Rs. 70.9 crore has been earmarked for funding capital expenditure for the proposed expansion
The injection is used to reverse the effects of the muscle relaxants given to patients during surgery
Lonza, a global manufacturing partner to the pharma, biotech and nutrition industries, has announced it will invest in additional drug product manufacturing capabilities in Switzerland
Labetalol hydrochloride injection USP is indicated for the control of blood pressure in severe hypertension.
This is Omeza’s first Rx product and the first drug/device combination matrix of its kind for chronic wound care
Subscribe To Our Newsletter & Stay Updated
